Literature DB >> 17422273

Preparation of Injectable Dantrolene for Emergency Treatment of Malignant Hyperthermia-like Syndromes.

P J O'brien, G W Forsyth.   

Abstract

Entities:  

Year:  1983        PMID： 17422273      PMCID： PMC1790375     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


× No keyword cloud information.
  6 in total

1.  Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.

Authors:  G G Harrison
Journal:  Br J Anaesth       Date:  1975-01       Impact factor: 9.166

2.  Parvovirus infection and distemper vaccination.

Authors:  L T Glickman; M J Appel
Journal:  J Am Vet Med Assoc       Date:  1981-05-15       Impact factor: 1.936

3.  Dantrolene and the treatment of malignant hyperthermia.

Authors:  G M Hall
Journal:  Br J Anaesth       Date:  1980-09       Impact factor: 9.166

4.  Capture myopathy in pronghorns in Alberta, Canada.

Authors:  G A Chalmers; M W Barrett
Journal:  J Am Vet Med Assoc       Date:  1977-11-01       Impact factor: 1.936

5.  Malignant hyperthermia in a halothane-anesthetized horse.

Authors:  E Waldron-Mease; L V Klein; H Rosenberg; M Leitch
Journal:  J Am Vet Med Assoc       Date:  1981-11-01       Impact factor: 1.936

6.  Dantrolene in human malignant hyperthermia.

Authors:  M E Kolb; M L Horne; R Martz
Journal:  Anesthesiology       Date:  1982-04       Impact factor: 7.892
  6 in total
  1 in total

1.  Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis.

Authors:  P J O'Brien; G W Forsyth; D W Olexson; H S Thatte; P B Addis
Journal:  Can J Comp Med       Date:  1984-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.